Jenburkt Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jenburkt Pharmaceuticals Ltd. on BSE

Load latest

Jenburkt Pharmaceuticals Ltd.

29 May 2023

1085.00

-1.35%

Company Update

JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24A (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Annual Secretarial Compliance Report, issued by the Practicing Company Secretary, for the year ended 31st March, 2023.

pdf

Jenburkt Pharmaceuticals Ltd.

24 May 2023, 12:49PM

1085.00

-1.35%

Company Update

JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed copies of the newspaper publication pertaining to the extract of the Audited Financial Results for the quarter and Financial Year ended March 31, 2023. The said extract was published in The Free Press Journal, Mumbai (English) and Navshakti, Mumbai (Marathi) newspapers, on 24th May, 2023.

pdf

Jenburkt Pharmaceuticals Ltd.

23 May 2023, 06:02PM

1085.00

-1.35%

Corp. Action

JENBURKT PHARMACEUTICALS LTD. - 524731 - Book Closure And Record Date

BSE India

The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive) for the purpose of payment of dividend, as recommended in the same meeting. The Board has also, fixed the cut-off date as Wednesday, 19th July, 2023, for the purpose of determining the eligibility of Shareholders eligible for remote e-voting or e-voting during the 38th AGM, scheduled on Wednesday, 26th July, 2023.

pdf

Jenburkt Pharmaceuticals Ltd.

23 May 2023, 05:24PM

1085.00

-1.35%

Corp. Note

JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

The Board of Directors at their meeting held on 23rd May, 2023 recommended a dividend of Rs.14.40 per equity share of Rs.10/- each.

pdf

Jenburkt Pharmaceuticals Ltd.

23 May 2023, 05:19PM

1085.00

-1.35%

Result

JENBURKT PHARMACEUTICALS LTD. - 524731 - Results-Financial Results For MAR-31 2023

BSE India

Outcome of Board Meeting held on 23rd May, 2023: The Board of Directors inter-alia approved the Audited Financial Statement for the year 2022-23 and recommended dividend of Rs.14.40 per equity share of Rs.10/- each.

pdf

Jenburkt Pharmaceuticals Ltd.

23 May 2023, 05:14PM

1085.00

-1.35%

Board Meeting

JENBURKT PHARMACEUTICALS LTD. - 524731 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

pdf

Jenburkt Pharmaceuticals Ltd.

23 May 2023

1085.00

-1.35%

Annual Report

Annual report for Jenburkt Pharmaceuticals Ltd. for FY-2023

None

pdf

Jenburkt Pharmaceuticals Ltd.

19 May 2023

1085.00

-1.35%

Corp. Note

JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Information regarding loss of share certificate and issuance of Letter of Confirmation of Daisy Yohanan(duplicate share certificate) in lieu hereof.

pdf

Jenburkt Pharmaceuticals Ltd.

15 May 2023

1085.00

-1.35%

Corp. Note

JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Information regarding loss of share certificate and issuance of Letter of Confirmation of Jignesh M. Takwani (duplicate share certificate) in lieu thereof.

pdf

Jenburkt Pharmaceuticals Ltd.

12 May 2023

1085.00

-1.35%

Board Meeting

JENBURKT PHARMACEUTICALS LTD. - 524731 - Board Meeting Intimation for Intimation Under Regulation 29(1) Of SEBI …

BSE India

JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 ,inter alia, to consider and approve Audited Financial Statements for the Financial Year 2022-23, to declare dividend, if any.

pdf

Is Jenburkt Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 64.29%

Sell 21.43%

Hold 14.29%